Nordic Nanovector ASA logo

NANO - Nordic Nanovector ASA Share Price

NOK32.92 3.6  12.2%

Last Trade - 13/09/19

Sector
Healthcare
Size
Small Cap
Market Cap £161.5m
Enterprise Value £123.0m
Revenue £n/a
Position in Universe 620th / 1473
Bullish
Bearish
Unlock NANO Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

NANO Revenue Unlock NANO Revenue

Net Income

NANO Net Income Unlock NANO Revenue

Normalised EPS

NANO Normalised EPS Unlock NANO Revenue

PE Ratio Range

NANO PE Ratio Range Unlock NANO Revenue

Dividend Yield Range

NANO Dividend Yield Range Unlock NANO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
NANO EPS Forecasts Unlock NANO Revenue
Profile Summary

Nordic Nanovector ASA is a Norway-based company active in the biotechnology industry. It is engaged in the development and commercialization of targeted therapeutics for hematological cancers. Its main product candidate is Betalutin, comprising a tumor-seeking anti-CD37 antibody conjugated to a low intensity radionuclide (Lutetium 177). It is designed improve treatment of Non-Hodgkin Lymphoma (NHL) and advanced through clinical development. Additionally, the Company is engaged in the development of its Antibody-Radionuclide-Conjugate (ARC) portfolio to treat various selected cancer indications. It has two subsidiaries, Nordic Nanovector GmbH and Nordic Nanovector Ltd.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated July 7, 2009
Public Since July 7, 2014
No. of Shareholders: 8,276
No. of Employees: 49
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Oslo Stock Exchange
Shares in Issue 55,113,696
Free Float (0.0%)
Eligible for
ISAs
SIPPs
NANO Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for NANO
Upcoming Events for NANO
Similar to NANO
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.